# Risk Management Plans to Mitigate the Potential for Drug Shortages - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/risk-management-plans-to-mitigate-the-potential-for-drug-shortages/bd27fc63-0c90-4718-abd5-2b5af99e540e

> FDA guidance document: Risk Management Plans to Mitigate the Potential for Drug Shortages. Issue date: May 19, 2022. Get complete insights and analysis.

---

## Details

- Title: Risk Management Plans to Mitigate the Potential for Drug Shortages
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-05-19
- Comment Close Date: 2022-07-19
- Last Changed: 2022-05-20
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0277">FDA-2022-D-0277</a>

## Related Documents

- [Labeling for Biosimilar and Interchangeable Biosimilar Products](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-and-interchangeable-biosimilar-products/54a5f712-03f5-4993-b0d7-6a1c2f261eff)
- [Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/pregnant-women-scientific-and-ethical-considerations-for-inclusion-in-clinical-trials/674ff9d8-e752-4113-b7fd-bc85b7646bd3)
- [Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products](https://www.globalkeysolutions.net/guidances/guidance-document/formal-meetings-between-the-fda-and-sponsors-or-applicants-of-pdufa-products/3344b1c7-a603-4d25-a0d9-fa9de797e2e7)